Andrea Incoronato Selected Research

Pharmaceutical Preparations

3/2011	Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement.
1/2008	Effects of Hsp90 inhibition in neuroblastoma: analysis of drug sensitivity, target modulation and the influence of bone marrow microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Incoronato Research Topics

Disease

2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2011 - 04/2010
2	Leukemia 03/2011 - 04/2010
1	Osteolysis 04/2010
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Neoplasms (Cancer) 01/2008
1	Neuroblastoma 01/2008

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 03/2011 - 01/2008
1	ABT-737IBA 03/2011
1	Biological ProductsIBA 03/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2008
1	tanespimycin (17AAG)IBA 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008

Therapy/Procedure

2	Therapeutics 04/2010 - 01/2008